Background Human papillomavirus (HPV)-driven oropharyngeal cancer (OPC) patients are
characterised by a better prognosis than their HPV-negative counterparts. However, this …

Tobacco-or human papillomavirus-driven oropharyngeal squamous cell carcinomas
(OpSCC) represent distinct clinical, biological and epidemiological entities. The aim of this …

Results Sixty-six HPV-positive OPSCC cases were examined, including 40 HPV+ OPSCC>
10 pack-year and 26 HPV+< 10 pack-year smokers. Disease-free and overall survival were …

Introduction HPV-driven oropharyngeal cancer (OPC) patients have a better prognosis than
their HPV-negative counterparts but several studies have suggested that among HPV …

Although tobacco use is an independent adverse prognostic feature in HPV (+)
oropharyngeal squamous cell carcinoma (OPSCC), the biologic features associated with …

Background Human papillomavirus (HPV)–associated oropharyngeal cancer is a disease
clinically and biologically distinct from smoking‐related head and neck squamous cell …

Background The incidence of oropharyngeal squamous cell carcinoma (OPSCC) in the US
is rapidly increasing, driven largely by the epidemic of human papillomavirus (HPV) …

Introduction: Human papillomavirus (HPV)-positive and HPV-negative oropharyngeal
squamous cell carcinomas (OPSCCs) are 2 distinct cancers, with HPV-positivity conferring a …

Objectives Despite improved survival rates of patients with HPV-associated OPSCC, a
subset has distant metastasis or develops local recurrence during follow-up. To investigate …

Background Tobacco and alcohol consumption are risk factors for head and neck squamous
cell carcinoma (HNSCC). Recently, whole-exome sequencing clarified that smoking …